(Q35839483)

10 August 2017

1 reference

title

Does bronchial hyperresponsiveness in asthma matter? (English)

1 reference

bronchial hyperresponsiveness

10 August 2017

1 reference

1 reference

Graeme P Currie

1

1 reference

10 August 2017

Catherine M Jackson

series ordinal

2

1 reference

10 August 2017

Brian J Lipworth

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

41

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

247-258

1 reference

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Anti-leukotrienes as add-on therapy to inhaled glucocorticoids in patients with asthma: systematic review of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Allergic respiratory disease: strategic targets for primary prevention during childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Association of airway responsiveness with asthma and persistent wheeze in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

The interrelationship among bronchial hyperresponsiveness, the diagnosis of asthma, and asthma symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Prevalence of bronchial hyperresponsiveness and asthma in a rural adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

A comparison of the validity of different diagnostic tests in adults with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Comparisons of peak diurnal expiratory flow variation, postbronchodilator FEV(1) responses, and methacholine inhalation challenges in the evaluation of suspected asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Methacholine challenge: test-shortening procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Determinants of airway hyperresponsiveness in mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Allergen sensitization and bronchial hyper-responsiveness to adenosine monophosphate in asthmatic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Allergen avoidance in the treatment of asthma and atopic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

How best to measure airway responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Effects of mediator antagonism on mannitol and adenosine monophosphate challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Measurement of airway hyperresponsiveness: new considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Exercise but not methacholine differentiates asthma from chronic lung disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Changes in bronchial responsiveness to inhaled histamine over four years in middle aged male smokers and ex-smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Bronchial responsiveness to adenosine 5'-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV(1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Adenosine provocation: a new test for allergic type airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

PC(20) adenosine 5'-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Comparative in vivo bioactivity of modern H1-antihistamines on AMP challenge in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Responsiveness to mannitol in asthmatic subjects with exercise- and hyperventilation-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Relationship between airway hyperresponsiveness to mannitol and adenosine monophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Airway inflammation in mild intermittent and in persistent asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Airway-stabilizing effect of long-acting beta2-agonists as add-on therapy to inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

The effect of salmeterol on markers of airway inflammation following segmental allergen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Dose response of inhaled corticosteroids on bronchial hyperresponsiveness: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Bronchoprotective effects of leukotriene receptor antagonists in asthma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Effects of adding either a leukotriene receptor antagonist or low-dose theophylline to a low or medium dose of inhaled corticosteroid in patients with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Second-line controller therapy for persistent asthma uncontrolled on inhaled corticosteroids: the step 3 dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120028582

21 January 2018

Identifiers

DOI

10.1081/JAS-120028582

1 reference

10 August 2017

1 reference